Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study


Tugal-Tutkun I. , KADAYIFÇILAR S., Khairallah M., Lee S. C. , Ozdal P., Ozyazgan Y. , ...More

OCULAR IMMUNOLOGY AND INFLAMMATION, vol.25, no.1, pp.62-70, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 1
  • Publication Date: 2017
  • Doi Number: 10.3109/09273948.2015.1092558
  • Title of Journal : OCULAR IMMUNOLOGY AND INFLAMMATION
  • Page Numbers: pp.62-70

Abstract

Purpose: To evaluate the safety and efficacy of gevokizumab for the treatment of Behcet's disease uveitis in a prospective, open-label, randomized phase 2 trial.